-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Reiterates Buy on Lyell Immunopharma, Maintains $44 Price Target

Benzinga·06/08/2026 15:42:14
Listen to the news
Needham analyst Gil Blum reiterates Lyell Immunopharma (NASDAQ:LYEL) with a Buy and maintains $44 price target.